Submitted by kBLASTER Team on
Los Altos, Calif., March 16, 2015 – Gauss Surgical today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Triton Canister App, the second core product in its Triton System™ portfolio, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. Now, in addition to estimating blood loss on surgical sponges, the system can accurately estimate blood loss in blood bearing canisters, giving clinicians a better picture of overall surgical blood loss.
The Triton Canister App provides a fast, easy, and accurate means of estimating blood loss in surgical suction containers. Using the iPad camera, the system captures snapshots of surgical canisters and sends the images to the cloud where sophisticated algorithms estimate the hemoglobin content and the blood loss regardless of confounding factors such as saline/irrigation fluid, ambient lighting variations, and hemolysis (red cell rupture).
“In developing the Triton Canister algorithm, we discovered various factors that alter the visual appearance of blood in a container, and confound our ability to measure it. Our challenge was to develop a highly accurate solution while preserving the simplicity that is critical to our users’ experience in the operating room,” said Siddarth Satish, Founder and Chief Technology Officer of Gauss Surgical.
Trying to determine if a digital health app or wearable is a FDA regulated medical device? kBLASTER® search can help determine the FDA jurisdiction status of your digital health product. Leverage kBLASTER® consulting experience on FDA guidances regarding mobile medical applications, general wellness products and medical device data systems to navigate a path for a non-FDA regulated product.
Looking for the cornerstone to a successful 510(k) clearance strategy? kBLASTER® FDA 510(k) search can quickly identify the best available primary predicate, multiple predicates or reference devices and manage those results effectively.